research use only

Cilofexor (GS-9674) FXR agonist

Cat.No.S6547

Cilofexor(GS-9674) is a potent, selective oral agonist of farnesoid X receptor (FXR) with an EC50 of 43 nM. It has demonstrated anti-inflammatory, antifibrotic effects, and reduced portal pressure in preclinical liver fibrosis models, showing potential therapeutic benefit for primary sclerosing cholangitis (PSC) and nonalcoholic steatohepatitis (NASH) research.
Jump to

Quality Control

Batch: S654701 DMSO]100 mg/mL]false]Water]Insoluble]false]Ethanol]Insoluble]false Purity: 99.45%
99.45

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (170.4 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 586.85 Formula

C28H22Cl3N3O5

Storage (From the date of receipt)
CAS No. 1418274-28-8 Download SDF Storage of Stock Solutions

Synonyms GS-9674 SMILES C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC(=C(C=C4)C5(CN(C5)C6=NC=CC(=C6)C(=O)O)O)Cl

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
FXR
43 nM(EC50)
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2025-11-26)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04971785 COMPLETED
Nonalcoholic Steatohepatitis
Gilead Sciences
2021-08-09 PHASE2
NCT03890120 TERMINATED
Primary Sclerosing Cholangitis
Gilead Sciences
2019-03-27 PHASE3
NCT04060147 TERMINATED
Primary Sclerosing Cholangitis; Compensated Cirrhosis
Gilead Sciences
2019-10-17 PHASE1
NCT03987074 COMPLETED
Nonalcoholic Steatohepatitis
Gilead Sciences
2019-07-29 PHASE2
NCT03449446 COMPLETED
Nonalcoholic Steatohepatitis
Gilead Sciences
2018-03-21 PHASE2
NCT02943447 TERMINATED
Primary Biliary Cholangitis
Gilead Sciences
2016-12-01 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.